The management of cirrhotic cardiomyopathy is generally similar to that of heart failure, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), loop and thiazide diuretics, aldosterone receptor antagonists, and beta-blockers. The gene discussed is ACE; the disease is heart failure.